Uptake of tumour necrosis factor – alpha inhibitor biosimilars for psoriasis: A drug utilisation study from BADBIR
BJD, 2023.
Phan DB, Bewley AP, Smith CH, Mackenzie T, Griffiths CEM, Lunt M, Warren RB, Yiu ZZN; BADBIR Study Group.
Read publication: BJD
Related
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with mo...
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Sec...
Risk of Major Cardiovascular Events in Patients With Psoriasis Receiving Biologic Therapies: A Prosp...
Contact Us
Find Us
The University of Manchester
First Floor Bright Building
Manchester Science Park
Manchester
M15 6GZ
0 Comments